Home/Oncolyze/Alex Stojanovic, PhD

AS

Alex Stojanovic, PhD

Chief Operating Officer

Therapeutic Areas

Oncology Hematology

Oncolyze Pipeline

Drug	Indication	Phase
OM-301	Acute Myelogenous Leukemia (AML)	Preclinical

Leadership Team at Oncolyze

Steven J. Evans, MD

Founder & Chief Executive Officer

Larry Altstiel, MD, PhD

Chief Scientific Officer

Barbara A. Carlin, CPA, MBA

Chief Financial Officer

View full Oncolyze profile